Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 2/20 | 0.32 |
| ▸ | RARG | P13631 | 2/20 | 0.32 |
| ▸ | RARA | P10276 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3992176 | 1.00 | RARB (0.32) | RARBRARGRARARXRACYP1A2 | |
| SCHEMBL3995271 | 0.73 | — | — | |
| SCHEMBL1040060 | 0.71 | — | — | |
| SCHEMBL9840299 | 0.70 | MAPT (0.51) | RARBRARGRARARXRACYP1A2 | |
| SCHEMBL9840296 | 0.70 | MAPT (0.51) | RARBRARGRARARXRACYP1A2 | |
| SCHEMBL1472108 | 0.68 | CYP1A2 (0.57) | RARBRARGRARARXRACYP1A2 | |
| SCHEMBL3307322 | 0.68 | CYP1A2 (0.57) | RARBRARGRARARXRACYP1A2 | |
| SCHEMBL1472109 | 0.68 | CYP1A2 (0.57) | RARBRARGRARARXRACYP1A2 | |
| SCHEMBL9240438 | 0.67 | — | — | |
| SCHEMBL28956424 | 0.64 | CYP1A2 (0.45) | RARBRARGRARARXRACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090298950-A1 | CYCLOPENTANE/CYCLOPENTENE ALDEHYDE OR KETONE DERIVATIVES AND THEIR USE AS ODORANTS | GIVAUDAN SA (CH) | 2009-12-03 | — | — | US | claimed |
| EP-2063964-A1 | CYCLOPENTANE/CYCLOPENTENE ALDEHYDE OR KETONE DERIVATIVES AND THEIR USE AS ODORANTS | Givaudan SA (CH) | 2009-06-03 | — | — | EP | claimed |
| WO-2008017183-A1 | CYCLOPENTANE/CYCLOPENTENE ALDEHYDE OR KETONE DERIVATIVES AND THEIR USE AS ODORANTS | GIVAUDAN SA (CH) | 2008-02-14 | — | — | WO | claimed |
| US-20090298950-A1 | CYCLOPENTANE/CYCLOPENTENE ALDEHYDE OR KETONE DERIVATIVES AND THEIR USE AS ODORANTS | GIVAUDAN SA (CH) | 2009-12-03 | — | — | US | disclosed |
| EP-2063964-A1 | CYCLOPENTANE/CYCLOPENTENE ALDEHYDE OR KETONE DERIVATIVES AND THEIR USE AS ODORANTS | Givaudan SA (CH) | 2009-06-03 | — | — | EP | disclosed |
| WO-2008017183-A1 | CYCLOPENTANE/CYCLOPENTENE ALDEHYDE OR KETONE DERIVATIVES AND THEIR USE AS ODORANTS | GIVAUDAN SA (CH) | 2008-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090298950-A1 | CYCLOPENTANE/CYCLOPENTENE ALDEHYDE OR KETONE DERIVATIVES AND THEIR USE AS ODORANTS | ALDH5A1, ALDH1A1, CBR3 | RARB 505/4885RARG 820/4885RARA 498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.